SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000903423-13-000230
Filing Date
2013-04-02
Accepted
2013-04-02 13:01:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 shang-13da2_0328.htm SC 13D/A 122739
  Complete submission text file 0000903423-13-000230.txt   124386
Mailing Address NO. 5 BUILDING, 998 HALEI ROAD ZHANGJIANG HI-TECH PARK PUDONG NEW AREA SHANGHAI F4 201203
Business Address NO. 5 BUILDING, 998 HALEI ROAD ZHANGJIANG HI-TECH PARK PUDONG NEW AREA SHANGHAI F4 201203 (86-21) 5132-0088
ShangPharma Corp (Subject) CIK: 0001499470 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85970 | Film No.: 13734287
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 817-871-4000
ShangPharma Holdings Ltd (Filed by) CIK: 0001565361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A